Annexon Inc (ANNX)
5.14
+0.15
(+3.01%)
USD |
NASDAQ |
Dec 04, 13:56
Annexon Price: 5.14 for Dec. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 03, 2024 | 5.25 | 5.43 | 4.83 | 4.99 | 1.778M |
| Dec 02, 2024 | 5.39 | 5.55 | 5.235 | 5.27 | 1.074M |
| Nov 29, 2024 | 5.32 | 5.47 | 5.30 | 5.39 | 757730.0 |
| Nov 27, 2024 | 5.28 | 5.50 | 5.27 | 5.34 | 1.027M |
| Nov 26, 2024 | 5.11 | 5.41 | 5.05 | 5.29 | 1.373M |
| Nov 25, 2024 | 5.14 | 5.35 | 5.065 | 5.10 | 2.534M |
| Nov 22, 2024 | 5.18 | 5.32 | 5.08 | 5.14 | 1.197M |
| Nov 21, 2024 | 5.16 | 5.44 | 5.06 | 5.17 | 2.221M |
| Nov 20, 2024 | 5.46 | 5.46 | 5.045 | 5.16 | 1.544M |
| Nov 19, 2024 | 5.51 | 5.62 | 5.35 | 5.46 | 1.432M |
| Nov 18, 2024 | 6.13 | 6.22 | 5.44 | 5.46 | 1.675M |
| Nov 15, 2024 | 6.49 | 6.49 | 6.02 | 6.12 | 1.917M |
| Nov 14, 2024 | 6.65 | 6.65 | 6.27 | 6.33 | 796052.0 |
| Nov 13, 2024 | 6.70 | 6.81 | 6.53 | 6.55 | 1.078M |
| Nov 12, 2024 | 6.90 | 6.93 | 6.535 | 6.61 | 1.671M |
| Nov 11, 2024 | 7.26 | 7.29 | 6.96 | 6.97 | 755904.0 |
| Nov 08, 2024 | 7.41 | 7.445 | 7.15 | 7.23 | 835777.0 |
| Nov 07, 2024 | 7.49 | 7.61 | 7.33 | 7.36 | 1.245M |
| Nov 06, 2024 | 7.50 | 7.625 | 7.28 | 7.47 | 1.577M |
| Nov 05, 2024 | 7.15 | 7.29 | 6.94 | 7.25 | 5.010M |
| Nov 04, 2024 | 7.22 | 7.345 | 6.85 | 7.09 | 1.446M |
| Nov 01, 2024 | 7.40 | 7.43 | 7.19 | 7.28 | 686142.0 |
| Oct 31, 2024 | 7.51 | 7.57 | 7.32 | 7.32 | 1.024M |
| Oct 30, 2024 | 7.62 | 7.62 | 7.48 | 7.54 | 612623.0 |
| Oct 29, 2024 | 7.54 | 7.629 | 7.33 | 7.57 | 1.380M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.63
Minimum
Oct 13 2023
35.01
Maximum
Mar 16 2021
10.67
Average
5.90
Median
Nov 11 2022
Price Benchmarks
| CEL-SCI Corp | 0.57 |
| AIM ImmunoTech Inc | 0.207 |
| IGC Pharma Inc | 0.355 |
| NovaBay Pharmaceuticals Inc | 0.60 |
| Protalix BioTherapeutics Inc | 1.615 |
Price Related Metrics
| Price to Book Value | 1.652 |
| Earnings Yield | -20.23% |
| Market Cap | 547.89M |